Polymer Therapeutics Designed for a Combination Therapy of Hormone‐Dependent Cancer
Authors:
- 17 June 2005
- journal article
- zuschrift
- Published by Wiley in Angewandte Chemie
- Vol. 117 (26) , 4129-4134
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- N-(2-Hydroxypropyl) methacrylamide Copolymer Conjugates2005
- HPMA Copolymer-1,5-Diazaanthraquinone Conjugates as Novel Anticancer TherapeuticsJournal of Drug Targeting, 2004
- Poly(amidoamine) Salt Form: Effect on pH-Dependent Membrane Activity and Polymer Conformation in SolutionBiomacromolecules, 2004
- Aromatase inhibitors for breast cancer: lessons from the laboratoryNature Reviews Cancer, 2003
- Design of Environment‐Sensitive Supramolecular Assemblies for Intracellular Drug Delivery: Polymeric Micelles that are Responsive to Intracellular pH ChangeAngewandte Chemie, 2003
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Tamoxifen: a most unlikely pioneering medicineNature Reviews Drug Discovery, 2003
- HPLC methods for the determination of bound and free doxorubicin, and of bound and free galactosamine, in methacrylamide polymer-drug conjugatesJournal of Pharmaceutical and Biomedical Analysis, 1996
- Polymer micelles as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymerJournal of Controlled Release, 1990
- Structure and properties of pharmacologically active polymersJournal of Polymer Science: Polymer Symposia, 1975